These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

836 related items for PubMed ID: 30338806

  • 1. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ, Zeng HX, Huang P, Wang S, Xie CH, Li SJ.
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
    [Abstract] [Full Text] [Related]

  • 2. Hsa-miR-497-3p impedes the proliferation and invasion of triple-negative breast cancer cells by controlling epithelial-mesenchymal transition through ZEB1 targeting.
    Dong Q, Chen H, Li Y, Kong Y, Geng C, Liu Y.
    Cell Mol Biol (Noisy-le-grand); 2023 Aug 31; 69(8):78-83. PubMed ID: 37715420
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-27a-3p Modulates the Wnt/β-Catenin Signaling Pathway to Promote Epithelial-Mesenchymal Transition in Oral Squamous Carcinoma Stem Cells by Targeting SFRP1.
    Qiao B, He BX, Cai JH, Tao Q, King-Yin Lam A.
    Sci Rep; 2017 Apr 20; 7():44688. PubMed ID: 28425477
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z, Li Y, Xu J, Ren Q, Yao J, Tian X.
    IUBMB Life; 2016 May 20; 68(5):394-402. PubMed ID: 27079864
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. miR-124 regulates EMT based on ZEB2 target to inhibit invasion and metastasis in triple-negative breast cancer.
    Ji H, Sang M, Liu F, Ai N, Geng C.
    Pathol Res Pract; 2019 Apr 20; 215(4):697-704. PubMed ID: 30611621
    [Abstract] [Full Text] [Related]

  • 8. Regulation of cancerous progression and epithelial-mesenchymal transition by miR-34c-3p via modulation of MAP3K2 signaling in triple-negative breast cancer cells.
    Wu J, Li WZ, Huang ML, Wei HL, Wang T, Fan J, Li NL, Ling R.
    Biochem Biophys Res Commun; 2017 Jan 29; 483(1):10-16. PubMed ID: 28069384
    [Abstract] [Full Text] [Related]

  • 9. Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer.
    Rhodes LV, Martin EC, Segar HC, Miller DF, Buechlein A, Rusch DB, Nephew KP, Burow ME, Collins-Burow BM.
    Oncotarget; 2015 Jun 30; 6(18):16638-52. PubMed ID: 26062653
    [Abstract] [Full Text] [Related]

  • 10. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P, Ni K, Ke J, Zhang W, Feng Y, Mao Q.
    Exp Biol Med (Maywood); 2018 Mar 30; 243(5):473-480. PubMed ID: 29368542
    [Abstract] [Full Text] [Related]

  • 11. Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.
    Zhao L, Li R, Xu S, Li Y, Zhao P, Dong W, Liu Z, Zhao Q, Tan B.
    Acta Biochim Biophys Sin (Shanghai); 2018 Feb 01; 50(2):171-180. PubMed ID: 29329360
    [Abstract] [Full Text] [Related]

  • 12. Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis.
    Fan MJ, Zou YH, He PJ, Zhang S, Sun XM, Li CZ.
    Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31092700
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
    Damiano V, Brisotto G, Borgna S, di Gennaro A, Armellin M, Perin T, Guardascione M, Maestro R, Santarosa M.
    Genes Chromosomes Cancer; 2017 Feb 28; 56(2):147-158. PubMed ID: 27717206
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-138-5p inhibits cell migration, invasion and EMT in breast cancer by directly targeting RHBDD1.
    Zhao C, Ling X, Li X, Hou X, Zhao D.
    Breast Cancer; 2019 Nov 28; 26(6):817-825. PubMed ID: 31243644
    [Abstract] [Full Text] [Related]

  • 16. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM, Lee WH, Wu AT, Lin YK, Wang LS, Wu CH, Yeh CT.
    J Nutr Biochem; 2015 Jun 28; 26(6):675-85. PubMed ID: 25792283
    [Abstract] [Full Text] [Related]

  • 17. Downregulation of miR-205 contributes to epithelial-mesenchymal transition and invasion in triple-negative breast cancer by targeting HMGB1-RAGE signaling pathway.
    Wang L, Kang FB, Wang J, Yang C, He DW.
    Anticancer Drugs; 2019 Mar 28; 30(3):225-232. PubMed ID: 30334817
    [Abstract] [Full Text] [Related]

  • 18. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.
    Li YY, Zheng XH, Deng AP, Wang Y, Liu J, Zhou Q, Cheng GY, Jiang Q.
    Eur Rev Med Pharmacol Sci; 2019 Dec 28; 23(23):10433-10442. PubMed ID: 31841197
    [Abstract] [Full Text] [Related]

  • 19. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C, Liu Z, Jin L, Zhang F, Peng X, Xiao Y, Wang X, Lyu Q, Cai X.
    Cell Physiol Biochem; 2018 Dec 28; 48(5):1928-1941. PubMed ID: 30092578
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
    Liang TC, Fu WG, Zhong YS.
    Eur Rev Med Pharmacol Sci; 2019 Nov 28; 23(22):9988-9995. PubMed ID: 31799668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.